1. Six pioneers artistically celebrated by the Andalusian Society of Nuclear Medicine

   • Poul F. Høilund-Carlsen
   • Salomé Sanz-Viedma

   Editorial 10 July 2020 Pages: 329 - 331

   

2. Clinical translation and implementation of optical imaging agents for precision image-guided cancer surgery

   • F. B. Achterberg
   • M. M. Deken
   • A. L. Vahrmeijer

   Original Article Open access 12 August 2020 Pages: 332 - 339

   

3. Machine learning-based analysis of [¹⁸F]DCFPyL PET radiomics for risk stratification in primary prostate cancer

   • Matthijs C. F. Cysouw
   • Bernard H. E. Jansen
   • Ronald Boellaard

   Original Article Open access 31 July 2020 Pages: 340 - 349

   

4. Histologic subtype classification of non-small cell lung cancer using PET/CT images

   • Yong Han
   • Yuan Ma
   • Xiuhua Guo

   Original Article 10 August 2020 Pages: 350 - 360

   

5. The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients

   • Zhengbo Song
   • Tianchi Liu
   • Ming Chen

   Original Article 13 August 2020 Pages: 361 - 371

   

6. ⁶⁸Ga-labelled desferrioxamine-B for bacterial infection imaging

   • Milos Petrik
   • Eva Umlaufova
   • Clemens Decristoforo

   Original Article Open access 30 July 2020 Pages: 372 - 382

   

7. Development of [⁸⁹Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer

   • Alessandra Cavaliere
   • Suxia Sun
   • Bernadette Marquez-Nostra

   Original Article 08 August 2020 Pages: 383 - 394

   

8. [⁶⁸Ga]Ga-NODAGA-E[(cRGDyK)]₂ PET and hyperpolarized [1-¹³C] pyruvate MRSI (hyperPET) in canine cancer patients: simultaneous imaging of angiogenesis and the Warburg effect

   • Andreas Clemmensen
   • Adam E Hansen
   • Andreas Kjaer

   Original Article Open access 03 July 2020 Pages: 395 - 405

   

9. Myocardial creep-induced misalignment artifacts in PET/MR myocardial perfusion imaging

   • Elia von Felten
   • Georgios Benetos
   • Ronny R. Buechel

   Original Article Open access 18 July 2020 Pages: 406 - 413

   

10. In vivo quantitative mapping of human mitochondrial cardiac membrane potential: a feasibility study

    • Matthieu Pelletier-Galarneau
    • Yoann Petibon
    • Nathaniel M. Alpert

    Original Article 27 July 2020 Pages: 414 - 420

    

11. Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease

    • Carmela Nappi
    • Rosario Megna
    • Alberto Cuocolo

    Original Article 11 August 2020 Pages: 421 - 427

    

12. The value of ¹⁸F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis

    • Narjess Ayati
    • Ramin Sadeghi
    • Andrew M. Scott

    Review Article 29 July 2020 Pages: 428 - 448

    

13. Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma

    • Vera Wenter
    • Nathalie L. Albert
    • Andrei Todica

    Original Article Open access 18 July 2020 Pages: 449 - 460

    

14. Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [¹⁸F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma

    • Domenico Albano
    • Mark Tulchinsky
    • Raffaele Giubbini

    Original Article Open access 13 August 2020 Pages: 461 - 468

    

15. Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

    • Stefano Fanti
    • Karolien Goffin
    • Anders Bjartell

    Original Article Open access 02 July 2020 Pages: 469 - 476

16. ⁶⁸Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer

    • Matthew J. Roberts
    • Andrew Morton
    • John Yaxley

    Short Communication 22 July 2020 Pages: 477 - 482

    

17. ⁶⁸Ga-PSMA PET/CT targeted biopsy for the diagnosis of clinically significant prostate cancer compared with transrectal ultrasound guided biopsy: a prospective randomized single-centre study

    • Le-Le Zhang
    • Wen-Cheng Li
    • Hong-Bin Sun

    Original Article Open access 30 July 2020 Pages: 483 - 492

    

18. PSMA whole-body tumor burden in primary staging and biochemical recurrence of prostate cancer

    • Allan Santos
    • Aline Mattiolli
    • Elba Etchebehere

    Original Article 13 August 2020 Pages: 493 - 500

    

19. False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial

    • Wolfgang P. Fendler
    • Jeremie Calais
    • Thomas A. Hope

    Short Communication Open access 17 August 2020 Pages: 501 - 508

    

20. Pelvic lymph-node staging with ¹⁸F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -

    • B. H. E. Jansen
    • Y. J. L. Bodar
    • A. N. Vis

    Original Article Open access 12 August 2020 Pages: 509 - 520

    

21. ¹⁸F-DCFPyL PET/CT for primary staging in 160 high-risk prostate cancer patients; metastasis detection rate, influence on clinical management and preliminary results of treatment efficacy

    • M. Wondergem
    • F. M. van der Zant
    • R. J. J. Knol

    Original Article 27 July 2020 Pages: 521 - 531

    

22. Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na⁺/K⁺-ATPase-density

    • Mads Ryø Jochumsen
    • Jens Sörensen
    • Lars Poulsen Tolbod

    Original Article Open access 18 August 2020 Pages: 532 - 542

    

23. Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patients

    • Borjana Bogdanovic
    • Andrei Gafita
    • Stephan G. Nekolla

    Original Article Open access 28 July 2020 Pages: 543 - 553

    

24. The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial

    • Umberto Capitanio
    • Gino Pepe
    • Francesco Montorsi

    Original Article 08 July 2020 Pages: 554 - 560

    

25. Comprehensive evaluation of ⁶⁸Ga-PSMA-11 PET/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma

    • Jie Gao
    • Qinfeng Xu
    • Hongqian Guo

    Original Article 04 July 2020 Pages: 561 - 569

    

26. 2-[¹⁸F]FDG PET/CT parameters associated with WHO/ISUP grade in clear cell renal cell carcinoma

    • Yanyan Zhao
    • Caixia Wu
    • Zhanli Fu

    Original Article 19 August 2020 Pages: 570 - 579

    

27. Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants

    • Ahmed Gabr
    • Ahsun Riaz
    • Riad Salem

    Short Communication 04 August 2020 Pages: 580 - 583

    

28. Hybrid PET/MRI in non-small cell lung cancer (NSCLC) and lung nodules—a literature review

    • Sara E. Dahlsgaard-Wallenius
    • Malene Grubbe Hildebrandt
    • Thomas Lund Andersen

    Review Article 27 July 2020 Pages: 584 - 591

29. ¹⁸F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders?

    • E Guedj
    • M Million
    • D Raoult

    Short Communication 30 July 2020 Pages: 592 - 595

    

30. Clinical validation of the novel HDAC6 radiotracer [¹⁸F]EKZ-001 in the human brain

    • Michel Koole
    • Donatienne Van Weehaeghe
    • Tonya M. Gilbert

    Original Article Open access 08 July 2020 Pages: 596 - 611

    

31. Clinical impact of ¹⁸F-FDG-PET among memory clinic patients with uncertain diagnosis

    • Giulia Perini
    • Elena Rodriguez-Vieitez
    • Agneta Nordberg

    Original Article Open access 31 July 2020 Pages: 612 - 622

    

32. A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy

    • Cyrus Ayubcha
    • Mona-Elisabeth Revheim
    • Abass Alavi

    Review Article 21 July 2020 Pages: 623 - 641

    

33. Aggressive Langerhans cell histiocytosis transformation of T cell acute lymphoblastic leukemia detected on ¹⁸F-FDG PET/CT

    • Jianjie Wang
    • Tianbin Song
    • Jie Lu

    Image of the Month 06 June 2020 Pages: 642 - 643

    

34. PET/CT with [⁶⁸Ga]gallium-oxine-labeled heat-denatured red blood cells for detection of dystopic splenic tissue

    • Martin Freesmeyer
    • Sebastian Gröber
    • Robert Drescher

    Image of the Month Open access 15 June 2020 Pages: 644 - 646

    

35. ⁶⁸Ga-NOTA-FAPI-04 PET/CT in a patient with primary gastric diffuse large B cell lymphoma: comparisons with [¹⁸F] FDG PET/CT

    • Guochang Wang
    • Xiao Jin
    • Xuejuan Wang

    Image of the Month 06 July 2020 Pages: 647 - 648

    

36. ¹⁸F-FDG PET/CT findings in a rare monomorphic epitheliotropic intestinal T cell lymphoma

    • Chongjiao Li
    • Yong He

    Image of the Month 06 July 2020 Pages: 649 - 650

    

37. [¹⁸F]FDG and ^[68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of tuberculous lesions

    • Bing Hao
    • Xiurong Wu
    • Haojun Chen

    Image of the Month 08 July 2020 Pages: 651 - 652

    

38. Incidental finding of COVID-19 infection after [⁶⁸Ga]Ga-PSMA-11 PET/CT imaging in a patient with prostate cancer

    • Camila Edith Stachera Stasiak
    • Fabrícius Rocha Cardoso
    • Paulo Henrique Rosado-de-Castro

    Image of the Month 24 July 2020 Pages: 653 - 654

    

39. Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer

    • Matthew J. Roberts
    • Andrew Morton
    • John Yaxley

    Correction 12 September 2020 Pages: 655 - 656